V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260016723 | 260009358 | 1.67 | 63.9 | Curative (C) | 2017-09-11 | 2017-09-21 | Cisplatin + Etoposide (5 day) | 02 | N | 260028213 | CISPLATIN + ETOPOSIDE |
| 260016724 | 260009362 | 1.74 | 90.6 | Curative (C) | 2017-11-20 | 2017-11-20 | BEAM | 2 | Y | 260028220 | LEAM |
| 260016725 | 260009363 | null | 55 | Curative (C) | 2018-04-26 | 2018-07-12 | BENDAMUSTINE | N | N | 260028224 | BENDAMUSTINE |
| 260016726 | 260014477 | 1.85 | 80.9 | null | 2018-01-23 | 2018-01-24 | ETOPOSIDE | 02 | N | 260028230 | ETOPOSIDE |
| 260016727 | 260014477 | 1.8 | 95 | Palliative (P) | 2015-02-28 | 2015-03-01 | BEAM | 02 | N | 260028230 | BEAM |
| 260016728 | 260009368 | 1.62 | 72 | Curative (C) | 2017-01-23 | 2017-01-23 | Carboplatin AUC 6 - 10 | N | N | 260028245 | CARBOPLATIN |
| 260016729 | 260009371 | 1.7 | 74.8 | Disease modification (D) | 2016-06-19 | 2016-06-23 | PACIFICO TRIAL | 02 | null | 260028265 | PACIFICO TRIAL |
| 260016730 | 260009376 | 1.88 | 64.8 | Curative (C) | 2011-06-28 | 2014-05-07 | Cisplatin + Etoposide (5 day) | N | N | 260028277 | CISPLATIN + ETOPOSIDE |
| 260016733 | 260009380 | 1.71 | null | null | 2015-06-28 | 2015-06-28 | ETOPOSIDE | N | N | 260028284 | ETOPOSIDE |
| 260016734 | 260009383 | 1.88 | 89 | Curative (C) | 2018-04-23 | 2018-05-11 | TIP | N | null | 260028288 | TIP |
| 260016735 | 260009384 | 1.84 | 81.6 | Palliative (P) | 2017-01-12 | 2017-02-03 | null | 02 | N | 260028297 | NOT MATCHED |
| 260016736 | 260016933 | 1.88 | 87.9 | null | 2017-01-03 | 2017-02-06 | Methotrexate High Dose (3g/m2) | N | N | 260028300 | PAC-PLAT |
| 260016737 | 260009385 | 1.62 | 60.6 | Curative (C) | 2016-11-13 | 2018-11-28 | IGEV R | null | null | 260028301 | CHOP |
| 260016738 | 260009391 | 1.77 | 87 | Not known (9) | 2013-10-02 | 2013-10-07 | LENALIDOMIDE | 2 | N | 260028305 | CHLORAMBUCIL |
| 260016739 | 260009394 | 1.55 | 101 | Curative (C) | 2017-04-24 | 2017-12-29 | ESHAP R | N | N | 260028311 | LENALIDOMIDE |
| 260016740 | 260009397 | 1.61 | null | Palliative (P) | 2018-07-31 | 2018-07-31 | Methotrexate High Dose (3g/m2) | 02 | N | 260028315 | RCEOP |
| 260016741 | 260009404 | 1.75 | 81.5 | Curative (C) | 2017-12-17 | 2017-12-18 | R-GDP | N | N | 260028348 | CYCLOPHOSPHAMIDE |
| 260016742 | 260009405 | null | 97 | Curative (C) | 2018-07-15 | 2018-07-15 | PAM x 2 post-surgery (cycles 3&4) | 02 | N | 260028368 | GEMCITABINE + OXALIPLATIN + PACLITAXEL |
| 260016743 | 260009409 | null | null | Curative (C) | 2016-09-30 | 2016-09-30 | GDP | 02 | N | 260028377 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 260016744 | 260009415 | null | 47.2 | Curative (C) | 2017-01-21 | 2017-01-21 | Cyclophosphamide High Dose | 2 | null | 260028390 | HYDROXYCARBAMIDE |
| 260016745 | 260009417 | 1.67 | 65 | Disease modification (D) | 2017-05-25 | 2017-06-30 | Gemcitabine + Oxaliplatin | N | N | 260028392 | DHAP |
| 260016746 | 260009418 | 1.7 | 68.9 | Palliative (P) | 2017-10-07 | 2017-10-07 | IVE | 02 | N | 260028398 | GEMCITABINE + OXALIPLATIN + PACLITAXEL |
| 260016747 | 260009419 | 1.71 | 92.2 | Palliative (P) | 2017-05-11 | 2017-06-27 | IVE | N | N | 260028399 | CHOP |
| 260016748 | 260009422 | 1.6 | 55.4 | c | 2015-10-09 | 2015-10-16 | Cyclophosphamide High Dose | N | N | 260028405 | DHAP |
| 260016749 | 260014497 | 1.77 | 65.8 | Disease modification (D) | 2018-12-28 | 2019-01-23 | CYCLOPHOSPHAMIDE | N | N | 260028405 | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE |
| 260016750 | 260009426 | 1.81 | 72 | Curative (C) | 2018-02-15 | 2018-02-23 | FCR Oral - Cycle 2 onwards | N | N | 260028419 | CARBOPLATIN + ETOPOSIDE |
| 260016751 | 260009432 | 1.67 | 69.7 | Curative (C) | 2015-03-04 | 2015-03-16 | Chlorambucil | N | N | 260028436 | FEC |
| 260016752 | 260009437 | 1.78 | 57.7 | Curative (C) | 2013-03-27 | 2013-03-30 | DA-EPOCH-R | N | N | 260028439 | CYCLO + RITUXIMAB + VINCRISTINE |
| 260016753 | 260009438 | 1.69 | 60 | Disease modification (D) | 2013-07-20 | 2013-07-21 | Imatinib 400mg | 02 | N | 260028440 | PIXANTRONE |
| 260016754 | 260009441 | 1.63 | 82 | d | 2016-05-18 | 2016-05-18 | CYCLO + RITUXIMAB + VINCRISTINE | N | N | 260028451 | BEAM + ALEMTUZUMAB |
| 260016755 | 260009447 | 1.76 | 68 | Palliative (P) | 2017-04-21 | 2017-07-15 | CHOP R + METHOTREXATE | N | N | 260028460 | CYCLOPHOSPHAMIDE |
| 260016756 | 260016941 | 1.8 | 84.6 | null | 2016-07-25 | 2016-07-18 | ESHAP | 2 | N | 260028467 | BENDAMUSTINE + OBINUTUZUMAB |
| 260016757 | 260009451 | 1.98 | 103.7 | Curative (C) | 2017-03-05 | 2017-03-11 | Methotrexate High Dose (3g/m2) | N | N | 260028483 | CYCLOPHOSPHAMIDE |
| 260016758 | 260009452 | 1.66 | null | Disease modification (D) | 2015-12-11 | 2016-09-25 | R Chlorambucil | N | N | 260028487 | ESHAP R |
| 260016759 | 260009456 | 1.73 | 71.3 | Curative (C) | 2014-06-17 | 2014-06-21 | DABRAFENIB | 02 | null | 260028489 | ESHAP R |
| 260016760 | 260009462 | 1.61 | 84 | Disease modification (D) | 2017-03-22 | 2017-03-22 | Triple Intrathecal | 2 | N | 260028515 | CAPECITABINE + OXALIPLATIN |
| 260016761 | 260009467 | null | 66 | Palliative (P) | 2019-02-03 | 2019-02-05 | DHAP - R | N | N | 260028519 | PIXANTRONE |
| 260016762 | 260009468 | 1.63 | 90.5 | Palliative (P) | 2015-11-24 | 2016-01-05 | LENALIDOMIDE | null | null | 260028529 | PMITCEBO |
| 260016763 | 260009470 | 1.63 | 88 | Palliative (P) | 2018-05-07 | 2018-05-13 | ESHAP | 02 | N | 260028530 | IFOSFAMIDE + PACLITAXEL |
| 260016764 | 260009474 | 1.81 | 71.1 | Curative (C) | 2018-10-13 | 2018-10-13 | R-GDP | 02 | N | 260028536 | FLAG + IDARUBICIN |
| 260016765 | 260009475 | 1.75 | 63 | Disease modification (D) | 2017-03-07 | 2017-03-07 | CISPLATIN + GEMCITABINE + RITUXIMAB | N | N | 260028540 | IBRUTINIB |
| 260016766 | 260009477 | 1.76 | 112.8 | Curative (C) | 2017-10-20 | 2017-10-20 | DHAP | 02 | N | 260028549 | IRINOTECAN |
| 260016767 | 260009480 | null | 57.1 | Curative (C) | 2013-07-16 | 2013-07-20 | IDARAM | 02 | null | 260028569 | DOXORUBICIN |
| 260016768 | 260009483 | 1.56 | 68 | Disease modification (D) | 2013-03-05 | 2013-07-18 | CYCLOPHOSPHAMIDE | N | N | 260028571 | CHLORAMBUCIL |
| 260016769 | 260014516 | 1.62 | 66.8 | Curative (C) | 2015-05-28 | 2015-05-28 | R Chlorambucil | 02 | N | 260028572 | CISPLATIN |
| 260016770 | 260014516 | 1.7 | null | Adjuvant (A) | 2013-07-08 | 2013-07-14 | R CODOX-M/ R IVAC | 02 | N | 260028572 | BRENTUXIMAB |
| 260016771 | 260014516 | 1.74 | 0 | Disease modification (D) | 2016-09-14 | 2017-02-20 | Gemcitabine + Oxaliplatin | N | N | 260028572 | R-EPOCH |
| 260016772 | 260009489 | 1.78 | null | Palliative (P) | 2019-01-24 | 2019-01-29 | Cytarabine intrathecal | 2 | N | 260028605 | METHOTREXATE |
| 260016773 | 260009493 | null | 87 | Curative (C) | 2015-02-14 | 2015-02-15 | Bendamustine + Obinutuzumab | N | N | 260028610 | ETOPOSIDE + IFOSFAMIDE + MTX |
| 260016774 | 260009497 | 1.58 | 63.4 | Disease modification (D) | 2015-09-03 | 2015-09-05 | GEMCITABINE | N | N | 260028618 | ALEMTUZUMAB |